, and Stephen R. Daniels, MD, PhD 4 I n 2013, the US Preventive Services Task Force, in an update of their 2003 report, concluded that there was insufficient evidence to assess the balance of benefits and harms of screening for primary hypertension in children and adolescents to prevent subsequent cardiovascular disease in childhood or adulthood. 1 The US Preventive Service Task Force used a review of published evidence to come to their conclusion. Their review produced an "I" Statement. This means that, based on their key questions, there is insufficient evidence for or against blood pressure screening in children and adolescents.
Although this report evaluated longitudinal studies focused on the relationship of hypertension in childhood and adult cardiovascular disease events, there was little review of intermediate cardiovascular outcomes during childhood and adolescence.
1 This is unfortunate as there is substantial evidence that elevated blood pressure in children and adolescents is already having an adverse effect on the heart, vasculature, and brain.
We review the evidence that elevated levels of systolic and diastolic blood pressure in children and adolescents are associated with abnormalities of cardiac structure and function, arterial structure and function, and neurocognitive function. We address 3 evidence-related questions: (1) Is there an association between pediatric hypertension and target organ abnormalities? (2) Does target organ injury predict adverse downstream outcomes either in concert with or independent of blood pressure elevations? and (3) Does treatment of hypertension in childhood and adolescence improve target organ injury?
Cardiac Structure and Function
The heart is a dynamic organ that responds to the body's needs for changes in cardiac output related to a variety of factors, including increased physical activity. This can occur with changes in heart rate, ventricular volume, or both. The heart is also responsive to changes in preload, resulting from changes in intravascular volume, and afterload related to changes in peripheral vascular resistance and blood pressure.
The response of the heart to chronically increased afterload is hypertrophy. Studies have now shown that this may result in changes in thickness of the ventricular wall and changes in the relative wall thickness, the ratio of the thickness of the left ventricular wall to the size of the ventricular chamber. 2 These alterations result in different patterns of geometry, ranging from normal to concentric remodeling, eccentric hypertrophy, and concentric hypertrophy. 3 Historically, there has been the sense that hypertrophy of the heart as a result of increased afterload is compensatory and adaptive. 4 However, more recent evidence raises concern that this may not be the case with hypertension and that the hypertrophied heart in response to blood pressure elevation is actually abnormal and maladaptive. 5 This line between adaptation and maladaptation may be quite difficult to define. Future studies with new approaches to evaluate the relationship of cardiac structure and function will be helpful to better define this.
In studies of adults, increased left ventricular mass and abnormal left ventricular geometry, particularly concentric hypertrophy, have been related to increased risk of adverse cardiovascular outcomes. 6 DeSimone et al demonstrated that increased left ventricular mass index at a level of 51g/m 2.7 mass is associated with a 4-fold increased risk of adverse cardiovascular outcomes in adults with hypertension. 7 Similarly, results have shown that adults with concentric left ventricular hypertrophy have significantly increased risk of myocardial infarction and stroke. 8 Results in adults have also shown that a reduction of left ventricular mass is associated with improved outcomes, 5 however, not all studies have demonstrated this. 9 An important question is whether children and adolescents with elevated blood pressure have changes in their left ventricular structure similar to that in adults, suggesting that they may be at increased lifetime risk of adverse cardiovascular consequences. In a study of children, adolescents and young adults with primary hypertension, Daniels et al showed that approximately 10% had left ventricular mass index at or above the 51g/m 2.7 cut-off value. 10 They also demonstrated that 46% had left ventricular mass index above the 95% percentile for age and sex. The prevalence of concentric remodeling, eccentric hypertrophy, and concentric hypertrophy was 9%, 30%, and 17%, respectively. 10 Other studies, including the Bogalusa Study and the Muscatine Study, have also demonstrated the association between increased blood pressure and left ventricular hypertrophy. 11, 12 Other pediatric studies have also confirmed the relationship of pediatric hypertension and abnormal cIMT Carotid intima-media thickness FMD Flow-mediated dilation PWV Pulse wave velocity TOD Target organ damage left ventricular geometry. 13 Data from the Coronary Artery Risk Development in Young Adults Study show that elevated blood pressure in late adolescence and young adulthood is associated with left ventricular hypertrophy and reduced left ventricular function in later life. 14, 15 Studies in adults have shown that pharmacologic treatment of hypertension can reduce the level of left ventricular mass index and the prevalence of left ventricular hypertrophy. 16 Some studies have also shown that regression of left ventricular hypertrophy with treatment of hypertension in adults independently predicts improved outcomes. 17 There have been fewer clinical trials of blood control in children, and even fewer that have included left ventricular mass index as an outcome. Although there is some evidence that reduction of blood pressure will reduce left ventricular hypertrophy and improve left ventricular geometry in children and adolescents, [18] [19] [20] this remains an important gap in the evidence.
A major concern with changes in cardiac structure associated with hypertension is that, over time, these structural changes will result in functional changes, ultimately resulting in heart failure. Increased concentric hypertrophy results in a stiff left ventricular wall which, in time, results in decreased ability of the left ventricular cavity to fill during diastole, or diastolic dysfunction. Diastolic dysfunction may then, over time, result in systolic dysfunction or the inability of the heart to supply adequate cardiac output resulting in the symptoms of congestive heart failure. Although heart failure is uncommon in children and adolescents with hypertension, it is important to evaluate whether early changes in diastolic or systolic function may be present. Navarini et al evaluated cardiac function using novel echocardiographic measures, such as 3-dimensional speckle tracking to measure left ventricular strain, twist and torsion in young patients with hypertension and normal controls. 21 They found that children with hypertension had significantly lower strain indices, as well as evidence of diastolic dysfunction by tissue Doppler imaging. These findings suggest impaired relaxation of the left ventricle, as well as impaired longitudinal systolic function in children and adolescents with hypertension. This study confirms the results of previous studies with respect to diastolic dysfunction in children with hypertension. 22, 23 These results, taken together, confirm that abnormalities of cardiac structure and function are present in children and adolescents with hypertension. The relatively high prevalence of increased left ventricular mass index demonstrates that children and adolescents experience important adverse changes in the heart early in the course of the disease process and at relatively low levels of blood pressure elevation. Long term, there are also concerns that left ventricular hypertrophy, especially as it gets to a more severe level, may be associated with increased fibrosis and may be irreversible, even with subsequent reduction of blood pressure. 24 The relatively high prevalence of cardiac abnormalities in children with hypertension raises the concern that the 95th percentile cut point for defining hypertension in children and adolescents may be too high and that abnormalities may be occurring at even lower levels of blood pressure historically considered to be borderline or to represent prehypertension.
Vascular Structure and Function
Hypertension in young individuals may also result in vascular damage.
Methods of Assessment.
There are a variety of modalities available for evaluating the vascular structure and function that fall into 3 categories: vascular structure, arterial stiffness, and endothelial function.
Carotid ultrasound for measurement of the intima-media complex is the most commonly used technique to assess vascular structure as it is recognized as reflecting overall atherosclerotic burden. 25 The femoral 26 and abdominal aorta 27 have also been imaged, but those waves are more difficult to obtain, are highly correlated to the carotid, and offer little benefit. Guidelines with details on use of the technique in children have been published. 28 Arterial stiffness measures the viscoelastic nature of the arterial wall 29 and can be measured with ultrasound or nonimaging methods. The ultrasound method involves measuring of the maximal and minimal diameters of the artery of interest (carotid, aorta, brachial, or femoral) and calculation of a variety of different stiffness measures. 28 Assessment of pulse wave velocity (PWV) is the most commonly employed nonimaging technique used. Tonometric and Doppler devices are available that measure the pulse transit time from the proximal artery (usually the carotid) to the distal artery of interest (radial, femoral, or dorsalis pedis). The distance between the 2 sites is measured and used to calculate the spread of the pulse propagation expressed as a velocity. A higher value indicates a stiffer vessel. Details regarding a variety of techniques to measure arterial stiffness in children and adolescents were published in an American Heart Association statement in 2015. 30 Endothelial function measures the ability of the endothelium to release nitric oxide in response to stress. Brachial flowmediated dilation (FMD) is considered the "gold standard." 28 The baseline diameter of the brachial artery is measured, an ischemic stimulus is applied (inflated blood pressure cuff for 5 minutes) and the percent increase in diameter after cuff release is measured with maximal dilation occurring somewhere from 60 to 120 seconds after release of the ischemic stimulus. Unfortunately, there is great biologic variability in FMD so it is difficult to measure reproducibly and may be unsuitable for younger individuals who cannot tolerate 5 minutes of cuff occlusion. 31 There are also nonultrasound methods including peripheral arterial tonometry for reactive hyperemic index, laser flow Doppler, and venous plethysmography, but none have been widely used in pediatrics or in adults with hypertension.
Vascular Target Organ Damage in Adults.
The Atherosclerosis Risk In Communities study was the first longitudinal cohort study that employed carotid intima-media thickness (cIMT), a measure of vascular structure, as a major endpoint. Atherosclerosis Risk In Communities investigators calculated a hazard ratio of 5.07 for women and 1.85 for men for Volume 202 • November 2018 incident coronary heart disease for subjects with a cIMT >1 mm over 4-7 years of follow-up, demonstrating that cIMT reflects generalized atherosclerosis. 25 Later, the Framingham Heart study demonstrated that a carotid-femoral PWV, a measure of central arterial stiffness, >11.8 m/seconds resulted in a 48% increase in cardiovascular risk over a median follow-up of 7.8 years. 32 A meta-analysis of over 15 000 subjects confirmed that a 1 m/second increase in PWV led to an age-, sex-, and cardiovascular risk factor adjusted increase of 14% in risk of cardiovascular events and 15% risk for cardiovascular mortality. 33 The Northern Manhattan Study found lower brachial artery FMD, a measure of endothelial function, predicted incident cardiovascular events in subjects with metabolic syndrome (hazard ratio 2.60). 34 In all of these studies, vascular structure, arterial stiffness, or endothelial function was an independent predictor of incident cardiovascular disease even after correction for concurrent levels of cardiovascular risk factors indicating the utility of vascular evaluation in risk stratification.
Vascular Target Organ Damage Related to Blood Pressure in
Youth. The origin of adult vascular target organ damage (TOD) is found in youth. 35, 36 The Bogalusa Heart Study showed that higher body mass index at around age 10 years, predicted a thicker cIMT by age 35 years. 37 Later, Bogalusa data were combined with cIMT data from the Cardiovascular Risk in Young Finns and Childhood Determinants of Adult Health studies where adolescents with dyslipidemia (high low-density lipoprotein or low high-density lipoprotein) were 1.6-2.5 times more likely to have a thicker cIMT measured at age 29-39 years. 38 When Muscatine Heart Study data were included, it was determined that childhood cardiovascular risk score measured as early as 9 years of age predicted high cIMT in adulthood. 39 Both the Bogalusa Heart Study 40 and the Young Finns studies 41 found that cardiovascular risk factors measured in youth, especially blood pressure 40, 42, 43 predicted PWV as an adult. Similarly, Young Finns and Childhood Determinants of Adult Health found passive smoke exposure at age 3-18 years predicted lower FMD 19-27 years later. 44 Clearly, control of cardiovascular risk factors in youth is essential to prevent the development of vascular TOD in adulthood.
Unfortunately, vascular TOD can be found in high-risk youth related to elevated cardiovascular risk factors. Higher cIMT is found in youth with obesity, 45 dyslipidemia, and clustering of cardiovascular risk factors. 46 Day et al performed a systematic review of over 300 articles to evaluate whether there was an independent relationship between blood pressure and cIMT in youth, and examined 28 of those studies that measured clinic blood pressure in detail. 47 These large and higher quality studies suggested higher blood pressure was related to higher cIMT even after adjusting for cardiovascular risk factors, but they did not see a clear threshold blood pressure for the observed effect. It should be noted that there may be a large difference in cIMT measures in children to different imaging protocols and the absolute values seen are much lower than values associated with hard cardiovascular events in adults (usually >1.0 mm). Kollias et al examined the relationship between ambulatory blood pressure and cIMT. In this meta-analysis, pediatric subjects with higher ambulatory blood pressure had on average a common carotid IMT 0.03 mm greater than their normotensive counterparts. 48 Similarly, increased arterial stiffness as measured by PWV, is also found in youth with obesity, 49 dyslipidemia, 50 and metabolic syndrome risk factor clustering. 46 Blood pressure levels also affect PWV. A recent study of 9-to 10-year-old children showed that carotid-femoral PWV in the top tertile was associated with higher mean blood pressure. 51 Two large studies also demonstrated higher PWV in adolescents with prehypertension even after adjustment for obesity, 52, 53 although it is clear that both obesity and blood pressure level adversely affect arterial stiffness (Figure) . 54 Adverse levels of ambulatory blood pressure measures have also been related to higher carotid-femoral PWV including increased daytime and nighttime systolic blood pressure load (% readings above the 95th percentile of blood pressure for the patient), 55 24-hour systolic blood pressure variability (SD), 56 and nondipping status. 57 Brachial-ankle PWV is another measure of arterial stiffness that has gained wide usage in Asia. Using this technique, large studies of children and adolescents have been performed demonstrating higher brachial-ankle PWV in healthy students related to higher mean arterial pressure 58, 59 and in youth diagnosed with sustained hypertension. 60 Similar to studies of cIMT, the absolute PWV value seen in high-risk youth (around 7 m/second) 49 is much lower than the threshold associated with hard cardiovascular events in adults (11.8 m/second). 32 Fewer studies in youth are available describing the relationship between blood pressure levels and endothelial function. In one of the earliest studies that included measures of blood pressure and FMD, Meyer et al evaluated 20 lean and 32 obese youth around 14 years of age and stratified them as having normal or reduced endothelial function with a cut-point of a brachial FMD of <5.55%. 61 The subjects with impaired arterial function had a higher prevalence of hypertension whether measured by clinic or ambulatory blood pressure monitoring.
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Figure. PWV is higher in obese, hypertensive, and combined obese-hypertensive children as compared with lean, normotensive controls (P < .0001). Because of small sample size (control = 49, hypertensive = 13, obese = 18, combined = 22), no significant difference was found among the 3 high-risk groups (adapted from Kulsum-Mecci).
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tion (FMD) measures and ambulatory blood pressure monitoring. There was no difference in clinic blood pressure between the groups, but the obese children had higher daytime and nighttime systolic blood pressure and diastolic blood pressure and had reduced FMD (lean = 8.3 + 1.7 vs obese 4.5 + 4.0%, P < .0001). 62 More recently, a larger study of 52 children (mean age 13 years) with risk factor clustering and 38 age-and sex-matched healthy controls evaluated brachial FMD and ambulatory blood pressure. 63 The high-risk group had significantly higher clinic systolic blood pressure and diastolic blood pressure and higher ambulatory mean blood pressures except for nighttime diastolic blood pressure and dipping and they had a significantly reduced FMD (cases = 6.8 + 3.3 vs controls = 11.8 + 5.7%, p < .001). 63 The importance of measuring vascular structure and function in youth is found in evidence linking vascular abnormalities to cardiac TOD in youth. When a "global" arterial stiffness index was calculated from 5 measures of central and peripheral arterial stiffness, a linear relationship was found between global stiffness and left ventricular mass index in 670 adolescents and young adults. 64 In the same cohort, a similar relationship was found between global stiffness and diastolic function 65 and between cIMT and cardiac strain. 66 In smaller studies, investigators have found a direct relationship between cIMT and left ventricular mass index in hypertensive youth 67 with cIMT remaining a significant predictor of left ventricular mass index in step-wise regression after adjustment for other factors. 68 Similarly, Koopman et al found that obese children (N = 48, mean age 14 years) had higher blood pressure than their lean counterparts and had higher cIMT and PWV and higher left ventricular mass index and reduced strain. However, they did not evaluate a direct correlation between the vascular and cardiac measures. 69 The largest study was performed in 2275 adolescents participating in the Special Turku Coronary Risk Factor Intervention Project where subjects with lower aortic and carotid distensibility were found to have higher left ventricular mass adjusted for age and sex. 70 The analyses were not indexed for height. 2.7 Unfortunately, there are limited data to suggest treatment of elevated cardiovascular risk factors in youth can lead to improvement in measures of TOD. Weight loss has been shown to result in reduction in both blood pressure levels and cIMT in children. 71 An exercise intervention was successful in lowering blood pressure and improving cIMT and carotid stiffness in prepubertal obese children. 72 FMD dropped a nonsignificant 0.6% in this small study of only 22 nonexercising obese and 22 exercising obese subjects. 72 Adherence to a Mediterranean diet was found to result in a lower reflected wave transit time, a variable related to PWV in a larger study of 275 children in Greece (mean age 12 years). 73 An intervention with the Dietary Approaches to Stop Hypertension in Youth diet has also been shown to improve blood pressure and FMD. 31 Finally, pharmacologic treatment of hypertension can produce reduction in cIMT with concomitant regression of left ventricular mass. 18 Clearly, vascular TOD in hypertensive youth is important as these abnormalities relate to cardiac TOD, and lifestyle and pharmacologic therapies can improve these intermediate outcomes. However, significant gaps in knowledge still exist. There is a lack of standardization of protocols for vascular measures in youth thus limiting pooling of data. This also leads to insufficiency in the amount of normative data on vascular TOD in youth across race/sex/ethnicity. Therefore, one cannot define "normal" or "abnormal" values for categorizing subjects with certainty. There is also a deficiency of longitudinal data across childhood and adolescence to determine the rate of normal vascular "aging" to compare with high-risk youth who may be experiencing "accelerated" vascular aging. Finally, there are no large, randomized clinical trials with either lifestyle or pharmacologic treatment to demonstrate regression of vascular TOD and normalization of cardiac measures with effective blood pressure lowering.
Sufficient data exist demonstrating that vascular TOD occurs in youth related to higher blood pressure levels. These types of intermediate outcomes have been linked to increased risk for cardiovascular events in adults. Because we cannot follow youth for decades without treatment of existing cardiovascular risk factors, more observational and interventional studies are needed to determine the threshold of blood pressure requiring intensification of treatment to improve vascular health.
Neurocognitive Function
Despite the strong association between early adult hypertension and subsequent stroke mortality, 74 little attention has been paid to the potential for hypertensive target organ damage to the brain in youth. Most descriptions of hypertensive target organ damage to the brain in children have been limited to gross neurologic events, such as facial palsy, seizure, and stroke, in children with malignant hypertension. However, evidence for more intermediate target organ damage to the brain in children with moderate hypertension is beginning to emerge, 75 and these findings have potential implications for the impact of childhood primary hypertension on the brain both during childhood and later in life. In addition, identifying substantive TOD markers earlier in development holds potential for early intervention and, perhaps, lessens and/or delays the downstream effects of chronic blood pressure elevation.
Findings in Young Adulthood
Studies indicate that hypertension from young adulthood influences cognition in midlife. The Coronary Artery Risk Development in Young Adults study showed that young adults (mean age, 25 years) with increased systolic blood pressure over 25 years had lower performance on measures of memory, processing speed, and executive function in middle age. 76 In another 20-year longitudinal study, Elias et al examined the relationship between hypertension and cognitive decline in young adults. The investigators found that young hypertensive adults were just as susceptible to subsequent blood pressure-associated November 2018
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cognitive decline as were older adults, and that the decline started in young adulthood. 77 Reports indicate that hypertension can also influence cognition even earlier in life. Studies in young adults indicate that primary hypertension is associated with decreased performance on neurocognitive testing compared with normotensive controls, particularly in the domains of attention, working memory, and executive function, a finding postulated to represent an early manifestation of hypertensive target organ damage to the brain. 78 The differences between young adults with hypertension and normotensive controls occur within the broad normal range of the neurocognitive tests. Young adults with primary hypertension are not cognitively impaired; instead, the lower scores on neurocognitive testing in hypertensive young adults represent relatively lower cognitive functioning only in comparison with those of normotensive controls.
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Findings in Children and Adolescents
More recent evidence shows that decreased performance on neurocognitive testing manifests even earlier in children and adolescents with hypertension, suggesting that hypertensive target organ damage to the brain can begin in youth. The relationship between elevated blood pressure and neurocognitive test performance in children was first investigated in a crosssectional analysis of children 6-16 years old who participated in NHANES III, a nationally representative sample of noninstitutionalized US children and adults. 80 After adjusting for socioeconomic status, obesity, and other demographic factors, elevated systolic blood pressure ≥90th percentile remained independently associated with lower Digit Span scores, a measure of verbal attention and working memory. Furthermore, the association between increased systolic blood pressure and lower Digit Span scores was more pronounced for children with systolic blood pressure in the hypertensive range, suggesting a dose-response effect of blood pressure on cognition.
A subsequent prospective, single-center study showed that children 10-18 years old with newly diagnosed, untreated primary hypertension had worse scores on parent ratings of executive function compared with matched normotensive control subjects. 81 The investigators went on to show that the parent ratings of executive function of subjects with hypertension improved significantly after 1 year of antihypertensive therapy, whereas the parent ratings of the control subjects did not change. 82 Another single center report of 14-year-old boys participating in a longitudinal study of the development of aggression found that subjects with systolic blood pressure in the high normal range had significantly lower performance on spatial learning and memory compared with subjects with lower systolic blood pressure, and that subjects with both a parental history of hypertension and systolic blood pressure in the high normal range had lower performance on verbal learning, suggesting that lower neurocognitive test performance in children may be detectable even within the normal spectrum of blood pressure, and that there may be a genetic predisposition to such deficits. 83 Results from a recent prospective multicenter study provide confirmation that children with primary hypertension perform lower on neurocognitive testing when compared with normotensive controls. 84 The investigators compared neurocognitive test performance of 75 untreated newly diagnosed 10-to 18-year-old subjects with hypertension to that of 75 frequency matched normotensive control subjects. The results showed that hypertension was independently associated with decreased performance on neurocognitive measures of verbal learning, memory, fine-motor dexterity, and vocabulary after controlling for socioeconomic status, obesity, disordered sleep, and other potential confounders. The effect sizes of the group differences were modest but increased when the hypertension group was limited to subjects with severe ambulatory hypertension and/or left ventricular hypertrophy, suggesting a dose effect of hypertension on neurocognitive test performance.
Furthermore, there was a significant interaction between disordered sleep, as measured by the Pediatric Sleep Questionnaire, 85 and hypertension on parent ratings of executive function, suggesting that children with disordered sleep are more likely to show decreased executive functioning skills if they also have hypertension. Similar to studies in young adults, the differences in neurocognitive test performance between hypertensive and control subjects occurred within the normal range of the neurocognitive measures: the subjects with hypertension were not found to be cognitively impaired. Primary hypertension in youth usually does not occur in isolation, but instead often clusters with other cardiovascular risk factors that may have further negative effects on cognition, including obstructive sleep apnea and metabolic syndrome. The cognitive effects of these cardiovascular risk factors may present challenges to some youth with hypertension.
The same study evaluated the effect of 1 year of antihypertensive therapy on neurocognitive test performance. Neurocognitive test performance of the hypertension subjects improved after 1 year of standard of care antihypertensive therapy; particularly on measures of verbal learning and memory, manual dexterity, and executive function. However, the control group also improved in the same measures with similar effect sizes, suggesting improvements with age or developmental maturation, or practice effects because of repeated neurocognitive testing, rather than improvement with treatment. Secondary analyses by effectiveness of the antihypertensive treatment suggest that the degree to which antihypertensive therapy improves blood pressure affects its impact upon neurocognitive function. Thirty-eight hypertension subjects with hypertension had successful treatment of their hypertension, whereas 17 of the participants had persistent ambulatory hypertension at 1 year, largely because of the presence of masked hypertension. As with results of the primary analyses, there was a similar degree of improvement at 1 year in neurocognitive test scores of the hypertension subjects with successful treatment and the control subjects. By contrast, the hypertension subjects with poor control of their hypertension did not show the same improvement in scores on measures of verbal memory or fine motor dexterity, THE JOURNAL OF PEDIATRICS • www.jpeds.com Volume 202 suggesting that they did not experience the same practice effect or normal growth in skills with age; their neurocognitive profile was unchanged at the end of the treatment period compared with baseline. The association between poor hypertension control and diminished practice effect or diminished growth in skills with age in some neurocognitive measures raises concern that the adequacy of hypertension treatment may have an impact on cognition over time. This suggests that undertreated hypertension in youth may contribute to lower cognitive functioning and could set the stage for cognitive decline later in life. 86 The Cardiovascular Risk in Young Finns Study 87 recently demonstrated that systolic hypertension in adolescence was associated with lower cognitive test performance in midlife. Specifically, this study followed nearly 3600 children, ages 3-18 years at study entry, for 31 years, with 2026 available for follow-up between the ages of 34 and 49 years. They reported that high systolic blood pressure, high total cholesterol, and smoking from childhood were significantly and independently related to poorer paired associative memory and learning functions in midlife. These findings are similar to those reported in the adult studies; however, importantly, this is one of the first studies to link early hypertension to poorer cognitive performance in later adult life.
The mechanism of lower neurocognitive test performance in hypertensive youth is not known, but there is evidence for altered cerebrovascular reactivity in hypertensive youth. Cerebrovascular reactivity reflects the capacity of cerebral blood vessels to dilate and may be an important marker for brain vascular reserve. Several studies have demonstrated blunted cerebrovascular reactivity to hypercapnia in hypertensive youth as measured by transcranial Doppler ultrasound, [88] [89] [90] and a recent small study showed a correlation between blunted cerebrovascular reactivity and worse parent ratings of executive function in hypertensive adolescents.
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Directions and Implications Based on the above emergent findings, there are several key areas of neurocognitive functioning that have the potential to relate to target organ damage in children and adolescents with hypertension, or perhaps even elevated blood pressure. These include fine-motor dexterity, memory, and learning across visual and auditory modalities, and overall executive function (ie, parent ratings). In this regard, it becomes important to include measures of these functions in studies examining target organ damage in children and adolescents, with a goal of having the potential to create common data elements across studies. Fortunately, there are a variety of well standardized and normed measures that are readily available to clinicians and investigators to assist in this more precise measurement of cognitive functioning. The emergent findings of slow motor dexterity, lower memory performance, and lower ratings of executive capabilities point to the early beginnings of frontal lobe dysfunction such that later regulatory abilities could be lessened, thus affecting overall adaptive functioning of the individual in later life. More longitudinal studies into adulthood are needed to further confirm this linkage between children and adolescents with (pre)hypertension and the problems associated with hypertension in later life.
Conclusions
We have outlined that abnormalities in cardiac structure and function, vascular structure and function, and neurocognitive function are present in children and adolescents with hypertension. Although there are still gaps in the evidence, including longitudinal studies to evaluate changes over time and clinical trials to demonstrate that treatment of elevated blood pressure results in improvement of these abnormalities, their presence in adults with hypertension are clearly associated with increased risk of morbidity and mortality. We outlined 3 important questions related to the evidence regarding the relationship of pediatric hypertension to target organ abnormalities in children and adolescents. The answer to question 1 is unequivocally "yes": the relationship of hypertension with cardiac, vascular, and neurocognitive abnormalities in children and adolescents has been shown in a variety of studies. Question 2, which focuses on the relationship of early target organ abnormalities on future cardiovascular disease, is more difficult to answer as it requires long term longitudinal data. However, the evidence appears to be accumulating that early target organ injury may predict future adverse outcomes and there is concern that some early target organ injury may be irreversible even with later treatment. The answer to question 3 regarding the impact of treatment of hypertension on target organ abnormalities requires randomized clinical trials that evaluate changes in target organ status as well as changes in blood pressure. Early studies do appear to support the concept that treatment of hypertension early in life does improve target organ status.
We need to continue to accumulate evidence to understand these relationships better. Future US Preventive Services Task Force reviews of blood pressure in children and adolescents should pay closer attention to this important evidence. The American Academy of Pediatrics has recently published clinical practice guidelines regarding the management of high blood pressure in children and adolescents. 92 The production of these guidelines included an extensive systematic review of the evidence and recommendations. In these guidelines, it is recommended that echocardiography be used to evaluate pediatric patients with hypertension for abnormalities of cardiac structure, geometry, and function at the time of consideration for pharmacologic treatment of hypertension. Although it is not currently recommended to measure vascular structure and function or neurocognitive function in the clinical setting, the evidence presented here is important in understanding the potential short-and long-term adverse effects of hypertension when it presents in childhood or adolescence. ■ Submitted for publication Mar 9, 2018 ; last revision received Jun 18, 2018; accepted Jul 6, 2018 November 2018
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